FTC:Watch Quotes Partner John Villafranco on Dismissal of Prevagen Case
October 13, 2017
Partner John Villafranco was quoted in the FTC:Watch article "Dismissal of Prevagen case deals tough blow to FTC." The article discusses the enforcement implications of the Federal Trade Commission and New York’s attorney general joining forces to sue Quincy Bioscience for deceptive advertising in promoting Prevagen, a dietary supplement. Mr. Villafranco, who represents Quincy Bioscience, noted that, "We are very pleased with the judge’s decision….We continue to believe that Quincy Bioscience has presented substantial evidence in support of its claims about Prevagen."